tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
US Market

Arbutus Biopharma (ABUS) Financial Statements

Compare
1,236 Followers

Arbutus Biopharma Financial Overview

Arbutus Biopharma's market cap is currently $668.27M. The company's EPS TTM is $-0.377; its P/E ratio is ―; Arbutus Biopharma is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 6.17M$ 18.14M$ 39.02M$ 10.99M$ 6.91M
Gross Profit$ 6.17M$ -55.56M$ 37.59M$ 9.23M$ -40.57M
Operating Income$ -76.32M$ -78.10M$ -65.46M$ -73.52M$ -57.81M
EBITDA$ -68.40M$ -70.99M$ -61.86M$ -71.64M$ -57.81M
Net Income$ -69.92M$ -72.85M$ -69.46M$ -77.35M$ -65.21M
Balance Sheet
Cash & Short-Term Investments$ 122.62M$ 126.00M$ 146.91M$ 155.32M$ 123.27M
Total Assets$ 131.71M$ 144.40M$ 195.42M$ 204.49M$ 137.08M
Total Debt$ 1.29M$ 8.72M$ 2.19M$ 2.61M$ 2.98M
Net Debt$ -35.04M$ -17.56M$ -28.59M$ -106.67M$ -49.27M
Total Liabilities$ 34.34M$ 38.38M$ 58.57M$ 35.05M$ 35.11M
Stockholders' Equity$ 97.37M$ 106.02M$ 136.85M$ 169.44M$ 101.97M
Cash Flow
Free Cash Flow$ -64.85M$ -86.94M$ -35.87M$ -68.34M$ -51.67M
Operating Cash Flow$ -64.85M$ -85.94M$ -35.36M$ -67.53M$ -51.44M
Investing Cash Flow$ 22.95M$ 50.77M$ -74.94M$ -12.68M$ -14.91M
Financing Cash Flow$ 52.00M$ 30.65M$ 31.81M$ 137.24M$ 86.75M
Currency in USD

Arbutus Biopharma Earnings and Revenue History

Arbutus Biopharma Debt to Assets

Arbutus Biopharma Cash Flow

Arbutus Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis